Market News AIOpen the app

TPST stock news · Tempest Therapeutics

Stories about Tempest Therapeutics (TPST) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for TPST

Follow Tempest Therapeutics (TPST) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TPST
Free on the App Store and Google Play, or on the web.
  1. Nov 1, 2026, 9:29 AM ET · New boss

    Tempest Therapeutics has named Stephanie Horn-Warnock as its new CFO after Constance Ames stepped down.

    Neutral

    Tempest Therapeutics named an experienced consultant as its new finance chief after the previous chief left for personal reasons. The change brings experience but no stated shift in the company's plans or results.

  2. Oct 23, 2026, 8:20 AM ET · Market

    12 health care companies are changing a lot in Friday's early trading.

    Neutral

    Tempest Therapeutics' shares rose about 10% to $0.58 in Friday's pre-market session. The report gives no company update, so the move alone does not change Tempest Therapeutics' business outlook.

  3. Oct 20, 2026, 4:13 PM ET · Market

    Tempest Therapeutics, Inc. is holding another meeting for stockholders to vote on a company rule change.

    Neutral

    Tempest Therapeutics lacked enough votes to approve a shareholder-rule change, so the meeting was postponed. The proposal remains undecided, with no reported change to company operations.

  4. Oct 19, 2026, 5:56 PM ET · Market

    Tempest Therapeutics, Inc. says some leaders are leaving, while new ones are being chosen and hired.

    Neutral

    Tempest filed a report with a section on officer and director changes, but the supplied text gives no details, so it does not change the company's outlook.

  5. Oct 12, 2026, 5:14 PM ET · Market

    12 health care companies saw big changes in their stock prices after the market closed on Monday.

    Neutral

    Tempest Therapeutics shares rose about 6%. The roundup gives no company news explaining the move, so it does not show a change in the company's business outlook.

  6. Sep 17, 2026, 5:47 PM ET · Market

    Tempest Therapeutics, Inc. has signed an important agreement with Heibei Senlang Biotechnology Co., Ltd.

    Neutral

    Tempest filed an 8-K for an exclusive collaboration with Heibei Senlang, but it disclosed no financial terms, so the filing does not change TPST's outlook today.

  7. Sep 17, 2026, 1:15 PM ET · Market

    On Thursday, 12 health care stocks changed a lot, with Aethlon Medical jumping 330.8% and Longeveron dropping 57.3%.

    Neutral

    Tempest's share decline is recorded here without new company disclosures, so the price move alone does not alter how we read the company.

  8. Sep 16, 2026, 5:18 PM ET · Market

    12 health care stocks changed a lot after the market closed on Wednesday.

    Neutral

    Tempest Therapeutics fell 7.44% after hours per the article, yet no company facts were reported, so the report does not change the company's view.

  9. Sep 16, 2026, 4:43 PM ET · Market

    Tempest Therapeutics, Inc. will hold a special meeting on October 14, 2026, for stockholders to vote on a proposal.

    Neutral

    Tempest adjourned a charter amendment vote after falling short of required support; the reconvening and proxy push leave the company view unchanged today.

  10. Sep 16, 2026, 8:18 AM ET · Market

    12 health care companies are changing prices before the market opens on Wednesday.

    Neutral

    The article reports TPST rose 40.21% to $1.06 in pre-market trading, but it gives no company news, so the report does not change how we read TPST.